Drugs / bone marrow mesenchymal stem cell-derived exosomes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07510295 | Jan → Jul 2025 | skin atrophy | Ngô Anh Tuấn | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow mesenchymal stem cell-derived exosomes | “This study is a randomized, double-blind, split-face, controlled prospective clinical trial designed to evaluate the efficacy and safety of human umbilical cord mesenchymal...” NCT07510295 ↗ |
| Known as | BM-MSC-exo | “This study is a randomized, double-blind, split-face, controlled prospective clinical trial designed to evaluate the efficacy and safety of human umbilical cord mesenchymal...” NCT07510295 ↗ |
| Modality | Other / unclassified | “Exosomes derived from mesenchymal stem cells (MSCs) have recently emerged as a promising adjunctive therapy in dermatology.” NCT07510295 ↗ |
| Route | Topical | “one side of the face was treated with a topical exosome solution” NCT07510295 ↗ |